Soleno Therapeutics, Inc. (SLNO) Misses Q3 EPS by 37c
Tweet
Share
E-mailGet Alerts SLNO Hot Sheet
Join SI Premium – FREE
Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q3 EPS of ($0.95), $0.37 worse than the analyst estimate of ($0.58).
For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
- Stifel Starts Tower Semiconductor (TSEM) at Buy, Top Pick
- Credo Technology Group Holding (CRDO) Tops Q1 EPS by 4c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
